In the first half of July 2025, the global Vitamin B12 market has showed signs of recovery after a prolonged downtrend that was driven by fresh production cycles and renewed procurement from downstream sectors such as pharmaceuticals, nutraceuticals and fortified food manufacturing. The absorption of earlier stockpiles prompted suppliers to initiate restocking, reflecting improved end-user offtake. Strategic pricing decisions and inventory realignment supported this upward trend. As the quarter advanced, buyers resumed order placements, responding to evolving demand patterns, with market participants anticipating a period of relative price stability and marginal upward movement.
